Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 167, Issue 2, 2013, Pages 194-198

  Iwase, Akira ^a,b   Sugita, Atsuko ^a,b   Hirokawa, Wakana ^a   Goto, Maki ^a,b   Yamamoto, Eiko ^a   Takikawa, Sachiko ^a   Nakahara, Tatsuo ^a   Nakamura, Tomoko ^a   Kondo, Mika ^a,b   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Anti M llerian hormone; Chemotherapy; Gestational trophoblastic neoplasia; Ovarian reserve

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLLITROPIN; METHOTREXATE; MUELLERIAN INHIBITING FACTOR; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CURETTAGE; FEMALE; FEMALE FERTILITY; FOLLITROPIN BLOOD LEVEL; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYDATIDIFORM MOLE; LOW RISK POPULATION; MENSTRUAL CYCLE; OVARIAN RESERVE; PRIORITY JOURNAL; TROPHOBLASTIC TUMOR;

EID: 84884211322     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2012.11.021     Document Type: Article

References (19)

1. W.H. Wallace Oncofertility and preservation of reproductive capacity in children and young adults Cancer 117 Suppl. 10 2011 2301 2310
2. S. Howell, and S. Shalet Gonadal damage from chemotherapy and radiotherapy Endocrinology and Metabolism Clinics of North America 27 1998 927 943
3. A. Chauhan, K. Dave, A. Desai, M. Mankad, S. Patel, and P. Dave High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience Journal of Reproductive Medicine 55 2010 333 340
4. L.A. Garrett, E.I. Garner, C.M. Feltmate, D.P. Goldstein, and R.S. Berkowitz Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia Journal of Reproductive Medicine 53 2008 481 486
5. M.M. Lee, P.K. Donahoe, and T. Hasegawa Mullerian inhibiting substance in humans: normal levels from infancy to adulthood Journal of Clinical Endocrinology and Metabolism 81 1996 571 576
6. A. de Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimullerian hormone serum levels: a putative marker for ovarian aging Fertility and Sterility 77 2002 357 362
7. S. Lie Fong, J.S. Laven, and F.G. Hakvoort-Cammel Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone Human Reproduction 24 2009 982 990
8. S. Lie Fong, P.J. Lugtenburg, and I. Schipper Anti-mullerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies Human Reproduction 23 2008 674 678
9. A.H. Partridge, K.J. Ruddy, and S. Gelber Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer Fertility and Sterility 94 2010 638 644
10. E.I. Kohorn Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report Journal of Reproductive Medicine 47 2002 445 450
11. A. Badawy, A. Elnashar, M. El-Ashry, and M. Shahat Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study Fertility and Sterility 91 2009 694 697
12. N.S. Macklon, and B.C. Fauser Ovarian reserve Seminars in Reproductive Medicine 23 2005 248 256
13. A. Iwase, W. Hirokawa, and M. Goto Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve Fertility and Sterility 94 2010 2846 2849
14. W. Hirokawa, A. Iwase, and M. Goto The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis Human Reproduction 26 2011 904 910
15. M. Rosendahl, C.Y. Andersen, N. la Cour Freiesleben, A. Juul, K. Lossl, and A.N. Andersen Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age Fertility and Sterility 94 2010 156 166
16. E.S. Newlands, M. Bower, and L. Holden The management of high-risk gestational trophoblastic tumours (GTT) International Journal of Gynaecology and Obstetrics 60 Suppl. 1 1998 S65 S70
17. C.A. Lok, C. van der Houwen, M.J. ten Kate-Booij, M.A. van Eijkeren, and A.C. Ansink Pregnancy after EMA/CO for gestational trophoblastic disease: a report from The Netherlands BJOG 110 2003 560 566
18. L.S. Dobson, P.C. Lorigan, R.E. Coleman, and B.W. Hancock Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease British Journal of Cancer 82 2000 1547 1552
19. B. Oriol, A. Barrio, A. Pacheco, J. Serna, J.L. Zuzuarregui, and J.A. Garcia-Velasco Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve Fertility and Sterility 90 2008 1579 1582